Open AccessHepatitis C in Children and Adolescents of a Brazilian Tertiary Center
Author(s) -
Camila Bellettini Hirsch,
Maria Fernanda Bádue Pereira,
Gabriel Núncio Benevides,
Tamires M Bernardes,
Giovanna Gavros Palandri,
Karina Lucio de Medeiros Bastos,
Ricardo Katsuya Toma,
Ramiro Anthero de Azevedo,
Heloísa Helena de Sousa Marques
Publication year - 2020
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000002725
Subject(s) - medicine , chronic hepatitis , pegylated interferon , hepatitis c , center (category theory) , pediatrics , virology , ribavirin , virus , chemistry , crystallography
We evaluated 113 pediatric patients with chronic hepatitis C from 2009 to 2019 at a Brazilian tertiary center. Seventy patients received pegylated-interferon treatment. The sustained virologic response was 61.4%, and 92.8% reported side effects. Currently, we are following 39 patients with chronic hepatitis C, 24 of whom are eligible for treatment with direct-acting antivirals according to Brazilian recommendations.